Tradestie Institutional Equity Comparison Engine
DXCM vs GEHC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DXCM Overall Edge
DXCM Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DexCom, Inc. (DXCM) driven by superior Growth & Margin, Momentum & Technical while GEHC counters with relative strength in Valuation, Options & Structure. Fundamentally, DXCM trades at 25.3x Forward P/E with 24.0% operating margin (+11.2% YoY revenue) versus GEHC at 14.7x Forward P/E and 13.8% operating margin (+7.2% YoY). In options structure, DXCM sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro) against GEHC sits in SURGE (8th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
GEHC
DXCM 25.3x vs GEHC 14.7x Fwd P/E
Growth & Margin Winner
DXCM
Op Margin 24.0% vs 13.8% ยท YoY +11.2% vs +7.2%
Momentum & Technical Winner
DXCM
1Y +32.8% vs +11.5% ยท 52W Pos 63% vs 71%
Options & Structure Winner
GEHC
CONSOLIDATION (15th %ile IV) vs SURGE (8th %ile IV)
DXCM
NASDAQ
DexCom, Inc.
Surgical & Medical Instruments & Apparatus
$79.32
-1.08% 1D
Market Cap
$29.9B
1M Return
+1.28%
1Y Return
+32.8%
Forward P/E
25.3x
Unified AI Score
50.8 / 100
HOLD
Tech 49.0
Fund 56.0
Flow 68.0
Mom 54.0
GEHC
NASDAQ
GE HealthCare Technologies Inc. Common Stock
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$80.64
-1.53% 1D
Market Cap
$37.0B
1M Return
+12.91%
1Y Return
+11.52%
Forward P/E
14.7x
Unified AI Score
38.6 / 100
SELL
Tech 29.0
Fund 44.0
Flow 59.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
DXCM +32.8%
GEHC +11.52%
Spread: +21.28 pp (DXCM Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | DXCM Revenue | GEHC Revenue | DXCM Op. Margin | GEHC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $1.03B | N/A | -18.1% | N/A | DXCM |
| FY2019 | $1.48B | N/A | 9.6% | N/A | DXCM |
| FY2020 | $1.93B | N/A | 15.5% | N/A | DXCM |
| FY2021 | $2.45B | $17.6B | 10.9% | 15.9% | GEHC |
| FY2022 | $2.91B | $18.3B | 13.4% | 13.8% | GEHC |
| FY2023 | $3.62B | $19.6B | 16.5% | 12.5% | DXCM |
| FY2024 | $4.03B | $19.7B | 14.9% | 13.3% | DXCM |
| FY2025 | $4.66B | $20.6B | 19.6% | 13.4% | DXCM |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DXCM | GEHC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $29.9B | $37.0B | Larger Scale | GEHC |
| Trailing P/E Ratio Valuation | 31.6x | 17.3x | Lower Multiple | GEHC |
| Forward P/E Ratio Valuation | 25.3x | 14.7x | Lower Multiple | GEHC |
| Revenue Growth (YoY) Growth | +11.2% | +7.2% | Higher Growth | DXCM |
| Operating Margin (TTM) Profitability | 24.0% | 13.8% | Higher Margin | DXCM |
| Net Profit Margin Profitability | 19.4% | 10.0% | Higher Margin | DXCM |
| Return on Equity (ROE) Capital Efficiency | 37.7% | 20.0% | Higher ROE | DXCM |
| 52-Week Range Position Momentum | 63% ($57โ$93) | 71% ($59โ$90) | Stronger Trend | GEHC |
| Beta / 30D Volatility Risk Regime | 0.59ฮฒ ยท 43% Vol | 0.52ฮฒ ยท 39% Vol | Lower Realized Risk | GEHC |
| Unified Institutional Score Composite Signal | 50.8 / 100 (HOLD) | 38.6 / 100 (SELL) | Higher Composite | DXCM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full DXCM vs GEHC Buy Guide
DXCM
CONSOLIDATION
73d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
15th %ile
IV Regime
Compressed (<25th %ile)
GEHC
SURGE
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither DXCM nor GEHC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.